Fundraising Fox
/People
Sign in

Doug Treco, Ph.D.

Investor

Advisor at Lightstone Ventures

Find your path to Doug

42 people in our graph can introduce you to Doug.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Mike Carusi to introduce you to Doug

You →Mike · together at Lightstone Ventures →Doug

Ask Jamie Chen to introduce you to Doug

You →Jamie · 11 people · together at Lightstone Ventures →Doug

Sign up to find every way you can get introduced to Doug

  • Your email: the people you already email who know Doug
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Doug
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Advisor to Lightstone Ventures and co-founder of Ra Pharmaceuticals, serving as CEO until its 2020 acquisition by UCB. Doug also co-founded Transkaryotic Therapies (acquired by Shire in 2005) and served as Entrepreneur-in-Residence at Morgenthaler Ventures.

Colleagues at Lightstone Ventures

Caroline Gaynor
Partner at Lightstone Ventures
Christina Isacson
Partner at Lightstone Ventures
Christina Isacson, Ph.D.
Partner at Lightstone Ventures
Doug Treco
Advisor at Lightstone Ventures
Frank D. Lee
Advisor at Lightstone Ventures
H. Martin Seidel
Advisor at Lightstone Ventures
H. Martin Seidel, Ph.D.
Advisor at Lightstone Ventures
Hank Plain
Founding Partner & Advisor at Lightstone Ventures

Frequently asked questions

Who is Doug Treco, Ph.D.?
Advisor to Lightstone Ventures and co-founder of Ra Pharmaceuticals, serving as CEO until its 2020 acquisition by UCB. Doug also co-founded Transkaryotic Therapies (acquired by Shire in 2005) and served as Entrepreneur-in-Residence at Morgenthaler Ventures.
Where does Doug Treco, Ph.D. work?
Doug Treco, Ph.D. is Advisor at Lightstone Ventures.